Enterprise Bank & Trust’s SELLAS Life Sciences SLS Stock Holding History

Enterprise Bank & Trust’s Portfolio SLS Stock Details SLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-462	Closed	-$3K	–	97
2019 Q3	$3K	Hold	462	–	–	﹤0.01%	88
2019 Q2	$3K	Buy	+462	New	+$16.4K	﹤0.01%	87

Other funds holding SLS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Leap Investments Chicago, Illinois $152M AUM 3.6% 1-Year Est. Return

Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Enterprise Bank & Trust's SLS Position: Q4 2019 in Review

Enterprise Bank & Trust sold out of SELLAS Life Sciences (SLS) in Q4 2019, closing a stake of 462 shares — an estimated $3K sold.

Enterprise Bank & Trust first reported a position in SLS in Q2 2019 and held it in 2 quarters. The position peaked at $3K in Q3 2019. 11 funds tracked by Wall St. Rank hold SLS as of Q4 2019.

Enterprise Bank & Trust reported no remaining SELLAS Life Sciences position as of Q4 2019 after selling out during the quarter.
Enterprise Bank & Trust sold 462 SELLAS Life Sciences shares in Q4 2019, an estimated $3K.
Enterprise Bank & Trust first reported a position in SELLAS Life Sciences in Q2 2019 and held it in 2 quarters.
Enterprise Bank & Trust's SELLAS Life Sciences position peaked at $3K in Q3 2019.
11 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q4 2019.

Based on Enterprise Bank & Trust's 13F filing for Q4 2019, filed 7 Jan 2020.